Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd vs Shanghai Haohai Biological Technology Co Ltd
A side-by-side look at two Chinese stocks — live quote, valuation, growth, listing venue, dual-listing and delisting status, and the WealthyTec Rank. A factual comparison for orientation, not investment advice.
| Metric | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 1349.HK · Hong Kong 2.43 HKD | Shanghai Haohai Biological Technology Co Ltd 6826.HK · Hong Kong 16.05 HKD |
|---|---|---|
| Day change | +2.53% | +0.88% |
| Market cap | $285.8M | $327.7M |
| P/E (TTM) | — | — |
| 2y EPS CAGR | — | — |
| WealthyTec Rank | 9.1 | 5.1 |
| Rank within sector | #3 of 31 | #14 of 31 |
| Listing venue | HKEX | HKEX |
| Other listings | n/a | n/a |
| Delisting filings | None on record | None on record |
| Sector | Health Care | Health Care |
| Industry | Medical Equipment and Devices | Biotech and Pharma |
Of the two, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd currently carries the higher WealthyTec Rank (9.1 vs 5.1). The Rank reflects past revenue, earnings and EPS trends only — not valuation, momentum, or the policy and delisting risks every China investor should weigh, and it is not a recommendation to buy, sell or hold either security. See our rank methodology.